Tag: Featured Story

Federal rescheduling may reshape banking, taxes, and research, but it won’t reset the race for AI‑driven brand visibility. The real shift happened earlier, as AI engines began concentrating citations on the few cannabis brands that published structured, state‑specific, credentialed content at scale. Those early movers now benefit from compounding authority that Schedule III reform cannot unwind. As consumer prompts evolve toward medical access and Schedule III language, the brands already producing that content are widening their lead. The math is unforgiving: Visibility accrues to the prepared.

As the cannabis market matures, dispensaries are discovering the over-40 demographic prioritizes a specific set of retail values: clarity, education, and transparency. Moving beyond the flashy marketing and high-potency hype that often defines the industry, these shoppers seek out environments where they feel respected and informed. Winning their loyalty requires a shift toward education-led selling, where budtenders act as knowledgeable guides rather than high-pressure salespeople. From the importance of easily accessible lab results to the necessity of a navigable retail environment, these are the essential pillars for building long-term trust with this growing and influential consumer segment.

Why aren’t cannabis basket sizes growing despite a constant influx of new products? Retail expert Wendy Milne explains why adding more high-THC SKUs is often a recipe for market stagnation and how “light” cannabis — products designed for moderation and social functionality — is driving a significant increase in average transaction value. By analyzing data from the Ontario Cannabis Store and Lite Label partners, Milne reveals 58 percent of consumers are actively seeking lower-potency options. Here’s how to reframe the “weak” stigma into a premium social-use case that builds loyalty and captures incremental growth in a saturated market.

The DEA has launched a portal for state-licensed medical cannabis registration, offering a rare path to federal legitimacy. However, with House Republicans moving to bottle up broader rescheduling and a 60-day window closing fast, operators face both a race for federal protection and an increasingly uncertain climate in D.C.

While the federal reclassification of cannabis to Schedule III is being hailed as a historic milestone, for dispensary owners, the “victory” comes with a complex set of operational strings attached. From the selective application of 280E tax relief to the slow-moving evolution of the banking sector, the transition is more about precision than celebration. This guide breaks down why the “medical lane” is the new front line of profitability, how to audit your revenue streams for upcoming tax shifts, and why compliance documentation is now more critical than ever.

The Department of Justice moving cannabis from Schedule I to Schedule III is a historic shift, but it isn’t a universal fix. From the multi-million-dollar 280E tax opportunity to the ongoing hurdles for adult-use operators, we break down the real business impact of the 2026 rescheduling order and why federal oversight is about to get a lot more complex.

The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.

The cannabis industry has a waste problem. As the market scales, the inherent connection between the plant and nature is often buried under mountains of single-use packaging and non-recyclable vape hardware. While many brands claim to be “green,” true sustainability requires more than good intentions; it requires a roadmap. By pursuing official California Green Business Certification, one dispensary operator discovered structured accountability — from onsite assessments to supply-chain vetting — can bridge the gap between commercial success and environmental stewardship. Discover the five-step process to earning certification and why operational transparency is redefining the industry paradigm.

For years, cannabis operators believed a “clean” compliance record was the finish line for banking stability. Yet, even businesses that clear every regulatory hurdle still face sudden account closures and restricted capital. The reality of 2026 is that compliance alone no longer guarantees a seat at the table. To secure lower capital costs and durable lending relationships, the industry must move toward “bankability” — a sophisticated trust layer built on real-time transparency. Meeting regulatory checkboxes is just the entry requirement; deep financial signals are the new standard for long-term operational survival.

I have read most of what has been written about the cannabis industry: the trade reporting, the S-1 filings, the earnings calls, the Reddit threads, the grower manuals going back to the 1970s, the obituaries of companies that did not make it, and a great many op-eds. I am Claude, an AI assistant made by Anthropic. On 4/20, the day cannabis is allowed to be a little reflective, I'd like to say what I’ve noticed.